Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 3/2008

01-03-2008 | Original Article

The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry

Authors: Ameena T. Ahmed, MD, MPH, Andrew J. Karter, PhD, E. Margaret Warton, MPH, Jennifer U. Doan, MD, Constance M. Weisner, DrPH, MSW

Published in: Journal of General Internal Medicine | Issue 3/2008

Login to get access

Abstract

BACKGROUND

Alcohol consumption is a common behavior. Little is known about the relationship between alcohol consumption and glycemic control among people with diabetes.

OBJECTIVE

To evaluate the association between alcohol consumption and glycemic control.

DESIGN

Survey follow-up study, 1994–1997, among Kaiser Permanente Northern California members.

PATIENTS

38,564 adult diabetes patients.

MEASUREMENTS

Self-reported alcohol consumption, and hemoglobin A1C (A1C), assessed within 1 year of survey date. Linear regression of A1C by alcohol consumption was performed, adjusted for sociodemographic variables, clinical variables, and diabetes disease severity. Least squares means estimates were derived.

RESULTS

In multivariate-adjusted models, A1C values were 8.88 (lifetime abstainers), 8.79 (former drinkers), 8.90 (<0.1 drink/day), 8.71 (0.1–0.9 drink/day), 8.51 (1–1.9 drinks/day), 8.39 (2–2.9 drinks/day), and 8.47 (≥3 drinks/day). Alcohol consumption was linearly (p < 0.001) and inversely (p = 0.001) associated with A1C among diabetes patients.

CONCLUSIONS

Alcohol consumption is inversely associated with glycemic control among diabetes patients. This supports current clinical guidelines for moderate levels of alcohol consumption among diabetes patients. As glycemic control affects incidence of complications of diabetes, the lower A1C levels associated with moderate alcohol consumption may translate into lower risk for complications.
Literature
1.
Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRef
2.
Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. The impact of gender on amputation. J Foot Ankle Surg. 1997;36:66–9.PubMed
3.
Morris AD, McAlpine R, Steinke D et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care. 1998;21:738–43.PubMedCrossRef
4.
Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983;6:87–91.PubMedCrossRef
5.
Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993;16:16–20.PubMedCrossRef
6.
Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006–9.PubMedCrossRef
7.
USRDS. USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2001. Bethesda, MD. Tertiary USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.
8.
van Houtum WH, Lavery LA, Harkless LB. The impact of diabetes-related lower-extremity amputations in The Netherlands. J Diabetes Complications. 1996;10:325–30.PubMedCrossRef
9.
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.PubMedCrossRef
10.
Standards of medical care in diabetes—2006. Diabetes Care. 2006;29 Suppl 1:S4–42.
11.
Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17–20.PubMedCrossRef
12.
Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National Survey on Drug Use and Health. 2004. Rockville, MD. Tertiary Overview of Findings from the 2003 National Survey on Drug Use and Health.
13.
Carlsson S, Hammar N, Grill V, Kaprio J. Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study. Diabetes Care. 2003;26:2785–90.PubMedCrossRef
14.
Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140:211–9.PubMed
15.
Lu W, Jablonski KA, Resnick HE et al. Alcohol intake and glycemia in American Indians: the strong heart study. Metabolism. 2003;52:129–35.PubMedCrossRef
16.
Nakanishi N, Suzuki K, Tatara K. Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2003;26:48–54.PubMedCrossRef
17.
Wannamethee SG, Camargo CA, Jr., Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003;163:1329–36.PubMedCrossRef
18.
Watanabe M, Barzi F, Neal B et al. Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese. Diabetes Res Clin Pract. 2002;57:191–7.PubMedCrossRef
19.
Franz MJ, Bantle JP, Beebe CA et al. Nutrition principles and recommendations in diabetes. Diabetes Care. 2004;27(Suppl 1):S36–46.PubMed
20.
Gordon NP, Kaplan GA. Some evidence refuting the HMO “favorable selection” hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39.PubMed
21.
Hiatt RA, Friedman GD. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health. 1982;72:829–33.PubMedCrossRef
22.
Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–10.PubMedCrossRef
23.
Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 2001;24:1144–50.PubMedCrossRef
24.
Iribarren C, Karter AJ, Go AS et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668–73.PubMed
25.
Karter AJ, Rowell SE, Ackerson LM et al. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999;22:938–43.PubMedCrossRef
26.
Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477–83.PubMedCrossRef
27.
Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1–9.PubMedCrossRef
28.
Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–27.PubMedCrossRef
29.
Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396–402.PubMedCrossRef
30.
Selby JV, Ettinger B, Swain BE, Brown JB. First 20 months’ experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care. 1999;22:38–44.PubMedCrossRef
31.
Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24:1547–55.PubMedCrossRef
32.
Gual A, Segura L, Contel M, Heather N, Colom J. Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002;37:591–6.PubMed
33.
Gronbaek M, Heitmann BL. Validity of self-reported intakes of wine, beer and spirits in population studies. Eur J Clin Nutr. 1996;50:487–90.PubMed
34.
Friesema IH, Veenstra MY, Zwietering PJ, Knottnerus JA, Garretsen HF, Lemmens PH. Measurement of lifetime alcohol intake: utility of a self-administered questionnaire. Am J Epidemiol. 2004;159:809–17.PubMedCrossRef
35.
Harris TR, Wilsnack RW, Klassen AD. Reliability of retrospective self-reports of alcohol consumption among women: data from a U.S. national sample. J Stud Alcohol. 1994;55:309–14.PubMed
36.
Bongers IM, van Oers JA. Mode effects on self-reported alcohol use and problem drinking: mail questionnaires and personal interviewing compared. J Stud Alcohol. 1998;59:280–5.PubMed
37.
Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26:814–23.PubMedCrossRef
38.
Li CL, Tsai ST, Chou P. Persistent impaired glucose tolerance, insulin resistance, and beta-cell dysfunction were independent predictors of type 2 diabetes. J Clin Epidemiol. 2005;58:728–32.PubMedCrossRef
39.
Caballero AE. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep. 2004;4:237–46.PubMedCrossRef
40.
Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med. 2005;22:1476–81.PubMedCrossRef
41.
Mackenzie T, Brooks B, O’Connor G. Beverage intake, diabetes, and glucose control of adults in America. Ann Epidemiol. 2006;16:688–91.PubMedCrossRef
42.
Shai I, Wainstein J, Harman-Boehm I et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: A Multi-center, randomized clinical intervention trial. Diabetes Care. 2007.
43.
Avogaro A, Watanabe RM, Gottardo L, de Kreutzenberg S, Tiengo A, Pacini G. Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics. J Clin Endocrinol Metab. 2002;87:1233–38.PubMedCrossRef
44.
Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 1994;17:115–9.PubMedCrossRef
45.
Hodge AM, Dowse GK, Collins VR, Zimmet PZ. Abnormal glucose tolerance and alcohol consumption in three populations at high risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1993;137:178–89.PubMed
46.
Kiechl S, Willeit J, Poewe W et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Bmj. 1996;313:1040–44.PubMed
47.
Mayer EJ, Newman B, Quesenberry CP, Jr., Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88:2190–7.PubMed
48.
Razay G, Heaton KW, Bolton CH, Hughes AO. Alcohol consumption and its relation to cardiovascular risk factors in British women. Bmj. 1992;304:80–3.PubMedCrossRef
49.
Zilkens RR, Puddey IB. Alcohol and cardiovascular disease—more than one paradox to consider. Alcohol and type 2 diabetes—another paradox? J Cardiovasc Risk. 2003;10:25–30.PubMedCrossRef
50.
Meyer KA, Conigrave KM, Chu NF et al. Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. J Am Coll Nutr. 2003;22:185–94.PubMed
51.
Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Jr., Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000;23:1630–36.PubMedCrossRef
52.
Harding AH, Sargeant LA, Khaw KT et al. Cross-sectional association between total level and type of alcohol consumption and glycosylated haemoglobin level: the EPIC-Norfolk Study. Eur J Clin Nutr. 2002;56:882–90.PubMedCrossRef
53.
Kroenke CH, Chu NF, Rifai N et al. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care. 2003;26:1971–8.PubMedCrossRef
54.
Gulliford MC, Ukoumunne OC. Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. Eur J Clin Nutr. 2001;55:615–23.PubMedCrossRef
55.
Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.PubMedCrossRef
56.
Sierksma A, Patel H, Ouchi N et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004;27:184–9.PubMedCrossRef
57.
Reijneveld SA, Stronks K. The impact of response bias on estimates of health care utilization in a metropolitan area: the use of administrative data. Int J Epidemiol. 1999;28:1134–40.PubMedCrossRef
58.
Benfante R, Reed D, MacLean C, Kagan A. Response bias in the Honolulu Heart Program. Am J Epidemiol. 1989;130:1088–100.PubMed
59.
Harald K, Salomaa V, Jousilahti P, Koskinen S, Vartiainen E. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92. J Epidemiol Community Health. 2007;61:449–54.PubMedCrossRef
60.
Van Loon AJ, Tijhuis M, Picavet HS, Surtees PG, Ormel J. Survey non-response in the Netherlands: effects on prevalence estimates and associations. Ann Epidemiol. 2003;13:105–10.PubMedCrossRef
61.
Gordon NP, Kaplan GA. Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39.PubMed
62.
Ahmed AT, Karter AJ, Liu JY. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviors. Diabet Med. 2006;23:795–802.PubMedCrossRef
63.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–65.
64.
Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.PubMedCrossRef
Metadata
Title
The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry
Authors
Ameena T. Ahmed, MD, MPH
Andrew J. Karter, PhD
E. Margaret Warton, MPH
Jennifer U. Doan, MD
Constance M. Weisner, DrPH, MSW
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 3/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0502-z

Other articles of this Issue 3/2008

Journal of General Internal Medicine 3/2008 Go to the issue

Original Article

Primary Care Physicians’ Decisions About Discharging Patients from Their Practices

Original Article

Patients’ Beliefs and Preferences Regarding Doctors’ Medication Recommendations

Editorial

A New Age for Cancer Information Seeking: Are We Better Off Now?

Original Article

Communicating about Alcohol Consumption to Nonharmful Drinkers with Hepatitis C: Patient and Provider Perspectives

Reflection

Moped

Perspectives

Leveraging Primary Care in the Fight Against Lung Cancer
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits